The sustainability of the Cancer Drugs Fund
The Pharmaceutical Journal held a panel discussion on the value of medicine at the RPS annual conference in Birmingham on 14 September 2015. Elizabeth Sukkar, the journal’s deputy news editor, asks key opinion leaders from NICE, the ABPI, the NHS and Myeloma UK on the sustainability of the Cancer Drugs Fund considering it is massively over budget. Read more about the panel discussion here.
Citation: The Pharmaceutical Journal URI: 20069492
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.